{
  "ptid_time": "007_S_0101_2006-07-07",
  "img_path": "/data/qiuhui/data/adni/images/007_S_0101/2006-07-07/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 60,703 mm³, 57.6% above the reference mean. With a Z-score of 1.38 (91.6th percentile), this represents mild enlargement; hippocampal volume measures 6,421 mm³, 15.1% below the reference mean. With a Z-score of -1.47 (7.1th percentile), this represents mild atrophy; whole brain volume measures 1,085,490 mm³, 0.6% above the reference mean. With a Z-score of 0.07 (52.9th percentile), this represents normal volume ; entorhinal cortex volume measures 2,772 mm³, 32.4% below the reference mean. With a Z-score of -2.20 (1.4th percentile), this represents significant atrophy; fusiform gyrus volume measures 15,135 mm³, 19.7% below the reference mean. With a Z-score of -1.67 (4.7th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 18,269 mm³, 14.4% below the reference mean. With a Z-score of -1.29 (9.8th percentile), this represents mild atrophy. ",
  "text_data": "Age is 74.1 years. Gender is Male. Education: 18 years. MMSE: 29.0. APOEε4 alleles: 2.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the entorhinal cortex and moderate atrophy in the fusiform gyrus, both key regions affected in Alzheimer's disease (AD). The hippocampal volume is mildly reduced, while ventricular enlargement suggests mild global atrophy. Despite the high MMSE score (29/30), the structural changes, particularly in AD-vulnerable regions, and the presence of two APOE4 alleles increase AD risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal AD given biomarker profile)  \n**Confidence:** **Medium** (high confidence in neurodegeneration, but clinical symptoms are minimal, making early AD vs. MCI less certain).  \n\n*Note: A follow-up CSF or amyloid PET would help confirm AD pathology.*",
  "timestamp": "2025-07-25T21:44:58.128232"
}